Type 2 diabetes mellitus and risk factors for cardiovascular disease. The advantage of choosing drugs iSGLT-2 and arGPP-1
AbstractThe aim of the study was to evaluate the effect of drugs SGLT-2 or arGPP-1 on the treatment of type 2 diabetes in patients with cardiovascular risks. As a result of the study, it was found that drugs of the SGLT-2 and arGPP-1 are especially attractive due to their positive influence on body weight, lipid profile, cardio- and nephroprotective effects.
Keywords: diabetes mellitus, risk factors
Funding. The study had no sponsor support.
Conflict of interests. The author declare no conflict of interests.
For citation: Adilyeva A.A. Type 2 diabetes mellitus and risk factors for cardiovascular disease. The advantage of choosing drugsiSGLT-2 and arGPP-1. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 88–9. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-88-89 (in Russian)